Skip to main content
. Author manuscript; available in PMC: 2013 Sep 5.
Published in final edited form as: Am Heart J. 2012 Mar 27;163(5):804–811. doi: 10.1016/j.ahj.2012.02.008

Figure 2.

Figure 2

Warfarin use at discharge among HF patients according to CHADS2 score. Among eligible HF patients with AF, warfarin use declined with increasing stroke risk defined by CHADS2 score (P<0.0001 for trend).